Company intelligence / Profile preview

RareLab

Palo Alto, California, United Statesrarelab.org ↗

Ownership: Private
Development stage: Other

Overview

Rarebase has launched a tech-enabled drug discovery platform called Function, collaborating with over 100 patient organizations to accelerate identification of potential therapeutics for hundreds of rare neurological and genetic disorders. The company leverages high-throughput technology and innovative financial models that allow direct support from patient groups. Early-stage research includes RNA studies and preclinical screens. No published late-stage clinical results as of June 2025.

Therapeutic areas: Rare DiseasesNeurology
Modalities: Small moleculeRNA therapyBiologic
Industry: Biotech

Partnerships

Over a hundred rare disease patient organizations including STXBP1 FoundationSynGAP Research FundFOXG1 Research FoundationHereditary Neuropathy FoundationHope4HarperADNP Kids Research Foundation

Beyond the preview

Go deeper on RareLab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RareLab.

Explore the full profile